Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced form of ...

编者按代谢功能障碍相关脂肪性肝病（MASLD）及代谢功能障碍相关脂肪性肝炎（MASH）是全球范围内日趋严重的健康问题。肝脏作为人体的代谢中心，通过整合来自胃肠道和脂肪组织的信号，调节碳水化合物、脂质和氨基酸的代谢。然而，肥胖、胰岛素抵抗和2型糖尿病等 ...

The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic methods for metabolic dysfunction–associated steatohepatitis (MASH).

Perspectum today released the results of a multinational study showing that LiverMultiScan can reduce liver biopsies, lead to fewer specialist consultations, and improve the rate of diagnosis for ...

MASLD becomes MASH. Not everyone living with MASLD develops MASH. Certain factors, including obesity, metabolic syndrome, age, and genetics, can play a role in the likelihood of progression.

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Semaglutide supports weight loss in MASLD/MASH for all diabetes groups The medication shows consistent effectiveness across groups, with no major differences in weight loss By reducing weight and ...

Young adulthood obesity is associated with greater odds for metabolic dysfunction-associated steatotic liver disease (MASLD), at-risk metabolic dysfunction-associated steatohepatitis (MASH), and ...